(Delisted)
$
42.97
11:08 PM EST
New Key Statistics Module, Z-Score and F-Score
NYSE:TARO Key Ratios
Market Cap $ M | 1,615.01 |
Enterprise Value $ M | 766.67 |
P/E(ttm) | 29.84 |
PE Ratio without NRI | 29.90 |
Forward PE Ratio | -- |
Price/Book | 0.90 |
Price/Sales | 2.57 |
Price/Free Cash Flow | 22.97 |
Price/Owner Earnings | 18.09 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 629.00 |
EPS (TTM) $ | 1.44 |
Beneish M-Score | -2.68 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -26.60 |
EV-to-EBIT | 35.68 |
EV-to-EBITDA | 14.58 |
PEG | -- |
Shares Outstanding M | 37.58 |
Net Margin (%) | 8.56 |
Operating Margin % | 3.42 |
Pre-tax Margin (%) | 13.14 |
Quick Ratio | 3.04 |
Current Ratio | 3.61 |
ROA % (ttm) | 2.51 |
ROE % (ttm) | 3.06 |
ROIC % (ttm) | 1.16 |
Dividend Yield % | -- |
Altman Z-Score | 3.57 |
TARO Number of Guru Trades
TARO Volume of Guru Trades
Gurus Latest Trades with NYSE:TARO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:TARO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Taro Pharmaceutical Industries Ltd Insider Transactions
No Available Data
News about NYSE:TARO
Total 0- 1